Regulators in the United States have recently approved a new prescription-only nasal spray for use against treatment-resistant depression. The FDA have approved a new medication for hard-to-treat depression. The Food and Drug Administration (FDA) have just granted approval of the drug esketamine (Spravato) to the Johnson & Johnson company Janssen Pharmaceuticals Inc. The fast-acting nasal